to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal Carcinoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Prospective Exploratory Clinical Study of Metronomic Capecitabine as Adjuvant Therapy in Locoregionally Advanced Hypopharyngeal Carcinoma (NCT05940441) | Eye & ENT Hospital of Fudan University | 2023-07-01 |
Track to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.